Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors
胸苷激酶1活性在接受CDK4/6和芳香化酶抑制剂治疗的激素受体阳性、HER2阴性转移性乳腺癌患者中的预后性能
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-025-07879-0
Brown, Nicole L; Howell, Sacha J; Papantoniou, Dimitrios; Eriksson, Olle; Bergqvist, Mattias; Williams, Amy; Kavanagh, Amy; Backlund, Alexandra; Albu-Kareem, Ahmed; Elinder, Ellinor; Larsson, Karolina; Uminska, Monika; Ekholm, Maria
CDK4
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌